Dysfunction of ventral striatal reward prediction in schizophrenia G Juckel, F Schlagenhauf, M Koslowski, T Wüstenberg, A Villringer, ... Neuroimage 29 (2), 409-416, 2006 | 749 | 2006 |
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics G Juckel, F Schlagenhauf, M Koslowski, D Filonov, T Wüstenberg, ... Psychopharmacology 187, 222-228, 2006 | 395 | 2006 |
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine F Schlagenhauf, G Juckel, M Koslowski, T Kahnt, B Knutson, T Dembler, ... Psychopharmacology 196, 673-684, 2008 | 267 | 2008 |
Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance M Wolff, R Evens, LJ Mertens, M Koslowski, F Betzler, G Gründer, ... Frontiers in psychiatry 11, 5, 2020 | 154 | 2020 |
Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia M Ballmaier, F Schlagenhauf, AW Toga, J Gallinat, M Koslowski, M Zoli, ... Schizophrenia research 106 (2-3), 140-147, 2008 | 99 | 2008 |
Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia G Juckel, E Friedel, M Koslowski, H Witthaus, S Özgürdal, Y Gudlowski, ... Neuropsychobiology 66 (1), 50-56, 2012 | 96 | 2012 |
Chorea in systemic lupus erythematosus JF Baizabal-Carvallo, M Alonso-Juarez, M Koslowski JCR: Journal of Clinical Rheumatology 17 (2), 69-72, 2011 | 69 | 2011 |
Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory F Schlagenhauf, T Wüstenberg, K Schmack, M Dinges, J Wrase, ... European Neuropsychopharmacology 18 (8), 589-599, 2008 | 61 | 2008 |
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE)–Rationale and study design LJ Mertens, M Koslowski, F Betzler, R Evens, M Gilles, A Jungaberle, ... Neuroscience Applied 1, 100104, 2022 | 28 | 2022 |
Novel treatment approaches for substance use disorders: Therapeutic use of psychedelics and the role of psychotherapy M Koslowski, MW Johnson, G Gründer, F Betzler Current Addiction Reports, 1-11, 2021 | 21 | 2021 |
Using routine MRI data of depressed patients to predict individual responses to electroconvulsive therapy M Gärtner, E Ghisu, AL Herrera-Melendez, M Koslowski, S Aust, P Asbach, ... Experimental neurology 335, 113505, 2021 | 16 | 2021 |
Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research M Koslowski, MP de Haas, T Fischmann Frontiers in Human Neuroscience 17, 1080177, 2023 | 8 | 2023 |
Cannabis use, use motives and cannabis use disorder among Berlin college students H Naegele, F Betzler, L Viohl, M Koslowski, F Ernst, MB Petzold Journal of Drug Issues 52 (4), 568-584, 2022 | 8 | 2022 |
Le rôle de la psychothérapie dans la thérapie assistée par les psychédéliques M Koslowski, C Dauré, M Ljuslin L'information psychiatrique 99 (10), 703-709, 2023 | 2 | 2023 |
Guiding Through Challenging Psychedelic Experiences and “Bad Trips” M Koslowski, P Gasser | 1 | 2024 |
Ethische Aspekte der Therapie mit Psychedelika D Repantis, M Koslowski, SB Fink Die Psychotherapie 69 (2), 115-121, 2024 | 1 | 2024 |
Ventral striatum activation by typical versus atypical neuroleptics in a fMRI paradigm with monetary incentive stimuli G Juckel, F Schlagenhauf, M Koslowski, D Filonow, B Knutson, J Wrase, ... Pharmacopsychiatry 38 (05), A109, 2005 | 1 | 2005 |
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research DB Yaden, M Graziosi, AM Owen, G Agin-Liebes, ST Aaronson, KE Allen, ... Psychedelic Medicine, 2025 | | 2025 |
Therapie mit Psychedelika M Koslowski, A Ströhle Die Psychotherapie 69 (2), 83-84, 2024 | | 2024 |
Ethical aspects of therapy with psychedelics D Repantis, M Koslowski, SB Fink PSYCHOTHERAPIE, 2024 | | 2024 |